SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 131 filers reported holding OREXIGEN THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.

Quarter-by-quarter ownership
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2014$16,000
+14.3%
2,5000.0%0.01%0.0%
Q4 2013$14,000
-6.7%
2,5000.0%0.01%
-16.7%
Q3 2013$15,0000.0%2,5000.0%0.01%
+20.0%
Q2 2013$15,0002,5000.01%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 3,000,000$5,160,0004.58%
Foresite Capital Management II, LLC 6,225,049$10,707,0003.59%
Scale Management, LLC 1,312,575$2,258,0003.46%
NEA Management Company, LLC 3,709,000$6,379,0000.41%
Cheyne Capital Management (UK) LLP 413,200$709,0000.38%
Rhenman & Partners Asset Management AB 1,189,000$2,045,0000.31%
SAMLYN CAPITAL, LLC 6,160,417$10,596,0000.22%
Rock Springs Capital Management LP 1,650,000$2,838,0000.22%
Palo Alto Investors LP 1,673,024$2,878,0000.16%
GLOBEFLEX CAPITAL L P 295,000$507,0000.14%
View complete list of OREXIGEN THERAPEUTICS INC shareholders